Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Viral vector containing DNA encoding the human SMN protein

EU orphan designation number: EU/3/11/876   
Active ingredient: Viral vector containing DNA encoding the human SMN protein
Indication: Treatment of 5q spinal muscular atrophy
Sponsor: University of Sheffield
Western Bank, Sheffield S10 2TN, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/06/2011 Centralised Orphan - Designation EMA/OD/169/10 (2011)4550 of 21/06/2011